Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
511.3 USD | -0.35% | +0.89% | +8.43% |
08:17am | News Highlights : Top Company News of the Day - Tuesday at 3 AM ET | DJ |
06:17am | News Highlights : Top Company News of the Day - Tuesday at 1 AM ET | DJ |
Financials (USD)
Sales 2024 * | 172B | Sales 2025 * | 182B | Capitalization | 119B |
---|---|---|---|---|---|
Net income 2024 * | 8.23B | Net income 2025 * | 9.1B | EV / Sales 2024 * | 0.78 x |
Net Debt 2024 * | 14.51B | Net Debt 2025 * | 11.06B | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
13.1
x | Employees | 104,900 |
Yield 2024 * |
1.22% | Yield 2025 * |
1.3% | Free-Float | 99.5% |
Latest transcript on Elevance Health, Inc.
1 day | -0.35% | ||
1 week | +0.89% | ||
Current month | +2.00% | ||
1 month | -0.26% | ||
3 months | +8.93% | ||
6 months | +15.49% | ||
Current year | +8.43% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 13-09-30 | |
Director/Board Member | 56 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 18 M€ | +5.16% | - | |
2.36% | 907 M€ | +7.80% | - | |
2.07% | 8 M€ | +5.61% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 511.3 | -0.35% | 724,224 |
24-03-15 | 513.1 | +0.49% | 1,444,877 |
24-03-14 | 510.6 | +0.21% | 1,062,865 |
24-03-13 | 509.5 | +0.78% | 924,621 |
24-03-12 | 505.6 | -0.24% | 689,589 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.43% | 119B | |
+17.76% | 100B | |
-24.16% | 41.85B | |
+3.79% | 41.2B | |
+13.57% | 23.96B | |
-2.34% | 3.5B | |
-45.76% | 883M | |
-17.74% | 388M |